Aurora Cannabis Gains Rights to Orally Dissolvable Thin Film Wafer Technology – New Cannabis Ventures

Convenient, High Bioavailability, Rapid Onset of Action Drug Delivery. EDMONTON, SASKATOON and HAMILTON, ON, April 16, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), CanniMed Therapeutics Inc

Read the full article from New Cannabis Ventures